Cargando…

Impact of bile acids on the growth of human cholangiocarcinoma via FXR

BACKGROUND: The objective of the study was to investigate the effect of different types of bile acids on proliferation of cholangiocarcinoma and the potential molecular mechanisms. METHODS: PCR assay and Western blot were performed to detect the expression of farnesoid × receptor (FXR) in mRNA and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jiaqi, Wang, Hongxia, Shi, Yihui, Dong, Ying, Zhang, Yinxin, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207959/
https://www.ncbi.nlm.nih.gov/pubmed/21988803
http://dx.doi.org/10.1186/1756-8722-4-41
_version_ 1782215586042871808
author Dai, Jiaqi
Wang, Hongxia
Shi, Yihui
Dong, Ying
Zhang, Yinxin
Wang, Jian
author_facet Dai, Jiaqi
Wang, Hongxia
Shi, Yihui
Dong, Ying
Zhang, Yinxin
Wang, Jian
author_sort Dai, Jiaqi
collection PubMed
description BACKGROUND: The objective of the study was to investigate the effect of different types of bile acids on proliferation of cholangiocarcinoma and the potential molecular mechanisms. METHODS: PCR assay and Western blot were performed to detect the expression of farnesoid × receptor (FXR) in mRNA and protein level. Immunohistochemical analysis was carried out to monitor the expression of FXR in cholangiocarcinoma tissues from 26 patients and 10 normal controls. The effects on in vivo tumor growth were also studied in nude mouse model. RESULTS: Free bile acids induced an increased expression of FXR; on the contrary, the conjugated bile acids decreased the expression of FXR. The FXR effect has been illustrated with the use of the FXR agonist GW4064 and the FXR antagonist GS. More specifically, when the use of free bile acids combined with FXR agonist GW4064, the tumor cell inhibitory effect was even more pronounced. But adding FXR antagonist GS into the treatment attenuated the tumor inhibitory effect caused by free bile acids. Combined treatment of GS and CDCA could reverse the regulating effect of CDCA on the expression of FXR. Administration of CDCA and GW 4064 resulted in a significant inhibition of tumor growth. The inhibitory effect in combination group (CDCA plus GW 4064) was even more pronounced. Again, the conjugated bile acid-GDCA promoted the growth of tumor. We also found that FXR agonist GW4064 effectively blocked the stimulatory effect of GDCA on tumor growth. And the characteristic and difference of FXR expressions were in agreement with previous experimental results in mouse cholangiocarcinoma tissues. There was also significant difference in FXR expression between normal and tumor tissues from patients with cholangiocarcinoma. CONCLUSIONS: The imbalance of ratio of free and conjugated bile acids may play an important role in tumorigenesis of cholangiocarcinoma. FXR, a member of the nuclear receptor superfamily, may mediate the effects induced by the bile acids.
format Online
Article
Text
id pubmed-3207959
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32079592011-11-04 Impact of bile acids on the growth of human cholangiocarcinoma via FXR Dai, Jiaqi Wang, Hongxia Shi, Yihui Dong, Ying Zhang, Yinxin Wang, Jian J Hematol Oncol Short Report BACKGROUND: The objective of the study was to investigate the effect of different types of bile acids on proliferation of cholangiocarcinoma and the potential molecular mechanisms. METHODS: PCR assay and Western blot were performed to detect the expression of farnesoid × receptor (FXR) in mRNA and protein level. Immunohistochemical analysis was carried out to monitor the expression of FXR in cholangiocarcinoma tissues from 26 patients and 10 normal controls. The effects on in vivo tumor growth were also studied in nude mouse model. RESULTS: Free bile acids induced an increased expression of FXR; on the contrary, the conjugated bile acids decreased the expression of FXR. The FXR effect has been illustrated with the use of the FXR agonist GW4064 and the FXR antagonist GS. More specifically, when the use of free bile acids combined with FXR agonist GW4064, the tumor cell inhibitory effect was even more pronounced. But adding FXR antagonist GS into the treatment attenuated the tumor inhibitory effect caused by free bile acids. Combined treatment of GS and CDCA could reverse the regulating effect of CDCA on the expression of FXR. Administration of CDCA and GW 4064 resulted in a significant inhibition of tumor growth. The inhibitory effect in combination group (CDCA plus GW 4064) was even more pronounced. Again, the conjugated bile acid-GDCA promoted the growth of tumor. We also found that FXR agonist GW4064 effectively blocked the stimulatory effect of GDCA on tumor growth. And the characteristic and difference of FXR expressions were in agreement with previous experimental results in mouse cholangiocarcinoma tissues. There was also significant difference in FXR expression between normal and tumor tissues from patients with cholangiocarcinoma. CONCLUSIONS: The imbalance of ratio of free and conjugated bile acids may play an important role in tumorigenesis of cholangiocarcinoma. FXR, a member of the nuclear receptor superfamily, may mediate the effects induced by the bile acids. BioMed Central 2011-10-12 /pmc/articles/PMC3207959/ /pubmed/21988803 http://dx.doi.org/10.1186/1756-8722-4-41 Text en Copyright ©2011 Dai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Dai, Jiaqi
Wang, Hongxia
Shi, Yihui
Dong, Ying
Zhang, Yinxin
Wang, Jian
Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title_full Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title_fullStr Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title_full_unstemmed Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title_short Impact of bile acids on the growth of human cholangiocarcinoma via FXR
title_sort impact of bile acids on the growth of human cholangiocarcinoma via fxr
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207959/
https://www.ncbi.nlm.nih.gov/pubmed/21988803
http://dx.doi.org/10.1186/1756-8722-4-41
work_keys_str_mv AT daijiaqi impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr
AT wanghongxia impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr
AT shiyihui impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr
AT dongying impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr
AT zhangyinxin impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr
AT wangjian impactofbileacidsonthegrowthofhumancholangiocarcinomaviafxr